Skip to main content
. 2024 Aug 12;38(13-14):e25089. doi: 10.1002/jcla.25089

FIGURE 1.

FIGURE 1

Peripheral blood smears (PBS) of patients taking alectinib. (A) PBS of patient A1, (B) PBS of patient A2, (C) PBS of patient A3, (D) PBS of patient A4, (E) PBS of patient A15 23 days after the start of alectinib use. Images of (A–E) shows 3+ acanthocytosis. (F) PBS of patient A15 before taking alectinib, which did not show significant acanthocytosis.